Chemed Corporation

Chemed Corporation

CHEยทNYSE

$426.86

-0.030%
HealthcareMedical - Care Facilities

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

At a Glance

Live Snapshot
Market Cap$5.67B
EPS18.4200
P/E Ratio23.17
Earnings Date08/04/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is mid-range (P/E 23.2).

Valuation inputs: P/E 23.2, earnings yield +4.3%, momentum -0.0%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is strong (ROE +27.1%, ROIC +17.9%).

Profitability stack: net margin +10.5%, ROE +27.1%, ROIC +17.9%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +40.3%, momentum -0.0%, net margin +10.5%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

che

Chemed Corporation Market vs Earnings Trajectory

CHE ยท NYSE
Current Price
$426.86
EPS (TTM)
$18.39

Performance Analysis

EPS Growth

-6.3%

Slight earnings decline may be temporary. Monitor future quarters for trend reversal.

Price-EPS Relationship

Aligned

Both price and earnings are declining together, reflecting deteriorating business fundamentals.

Stock Price Change

-24.0%

Over the 1Y period, stock price has decreased by 24.0%.

P/E Ratio (TTM)

23.2x

Moderate P/E ratio suggests fair market valuation relative to earnings.

Chemed Corporation

Chemed Corporation Fair Value Envelope

CHE ยท NYSE

Our analysis suggests that CHE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $426.86, this represents a potential HIDDEN relative to our calculated worth for Chemed Corporation.

Intrinsic Value
Current Price: $426.86
3Y+10.0%
5Y-8.0%
10Y+177.0%
3Y+19.0%
5Y+22.0%
10Y+60.0%
3Y+6.0%
5Y-17.0%
10Y+144.0%
3Y+25.0%
5Y-21.0%
10Y+187.0%
3Y+29.0%
5Y-24.0%
10Y+240.0%
3Y+14.0%
5Y+14.0%
10Y+86.0%
Chemed Corporation

Chemed Corporation Profit Bridge

CHE ยท NYSE
Revenue2.53B
Cost of Goods Sold (1.77B)
Gross Profit758.34M
Operating Expenses (417.19M)
Operating Income338.25M
Interest Expense (1.75M)
Other Income/Expense17.53M
Pretax Income355.78M
Income Tax (90.54M)
Net Income265.24M
Net Income
265.24M

Profitability Analysis

Gross Margin

30.0%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

13.4%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

10.5%

Strong net margins indicate efficient operations and favorable tax/interest management.

Effective Tax Rate

25.4%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.

29.97%
Gross Profit Margin
-15%
3Y-16.0%
5Y-11.0%
10Y+2.0%
13.37%
Operating Profit Margin
-11%
3Y-17.0%
5Y-29.0%
10Y+18.0%
10.48%
Net Profit Margin
-16%
3Y-10.0%
5Y-32.0%
10Y+52.0%
27.08%
Return on Equity
3Y-13.0%
5Y-24.0%
10Y+31.0%
16.17%
Return on Assets
-11%
3Y-7.0%
5Y-27.0%
10Y+31.0%
17.95%
Return on Invested Capital
-8%
3Y-18.0%
5Y-33.0%
10Y+17.0%
CHE

Chemed Corporation Cash Conversion Engine

CHE ยท NYSE
Net Income265.24M
Depreciation & Amortization64.84M
Stock-Based Compensation4.89M
Change in Working Capital23.71M
Others35.54M
Capital Expenditures-62.80M
Free Cash Flow325.48M

Cash Flow Quality Analysis

FCF Conversion Rate

122.7%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

16.2%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

-11.5%

Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.

Working Capital Impact

+$23.71M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Cash Flow Quality Insight

Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.

che

Chemed Corporation Funding & Solvency Profile

CHE ยท NYSE
Cash & Cash Equivalents16.86M
Net Receivables215.48M
Inventory7.21M
Other Current Assets0.00
Total Current Assets274 M
Property, Plant & Equipment133.60M
Goodwill & Intangible Assets767.92M
Long-Term Investments143.78M
Other Non-Current Assets216.46M
Total Non-Current Assets494 M
Total Assets
1.54B

Financial Health Analysis

Current Ratio

0.85x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

0.81x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

-47352000

Negative working capital indicates short-term liabilities exceed short-term assetsโ€”potential liquidity stress.

Asset Composition

18% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Negative working capital with limited cash reserves requires immediate attentionโ€”potential liquidity crisis if not addressed promptly.

che

Chemed Corporation Street Expectations Map

CHE ยท NYSE

Wall Street analysts project that CHE stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 475.00, with estimates ranging from a low of 475.00 to a high of 475.00.

Lowest Target
475.00
11.28%
Consensus Target
475.00
11.28%
Highest Target
475.00
11.28%

The consensus 1-year price target stands at 475.00, with estimates ranging from a low of 475.00 to a high of 475.00.

Analyst Consensus Analysis

Upside Potential

+11.3%

Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

High

Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

che

Chemed Corporation Insider Positioning

CHE ยท NYSE

During the last 12 months, insiders have purchased $83K and sold $9.86M worth of CHE shares, resulting in $9.77M of net selling activity.

3 Months

Bought

0

0.00

Sold

6.1K

2.45M

Net Activity

-2.4M

-$2.45M

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

5.2K

2.33M

Net Activity

-2.3M

-$2.33M

9-12 Months

Bought

200

83.42K

Sold

12.0K

5.08M

Net Activity

-5.0M

-$5.00M

Top Buyers

1
WGJI

Walsh George J Iii

Director

200 sharesโ€ข1 transactions

$83K

Top Sellers

1
MKJ

Mcnamara Kevin J

Director, Officer: President And Ceo

12.5K sharesโ€ข6 transactions

$5.32M

2
WNM

Westfall Nicholas Michael

Officer: Executive Vice President

10.0K sharesโ€ข1 transactions

$4.22M

3
WGJI

Walsh George J Iii

Director

500 sharesโ€ข1 transactions

$219K

4
GPP

Grace Patrick P

Director

210 sharesโ€ข2 transactions

$95K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $9.77M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.01:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$2.45M

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

4 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

0.16%
Dividend Yield
11%
3Y+124.0%
5Y+114.0%
10Y-10.0%
ย 

che Dividend History

CHE
10Y CAGR +10%
Latest $0.6
Annual $2.9
5 year growth trend
Last Period: +0%